Net profit for the September quarter was ₹878 crore, a 35% drop from ₹1,353 crore a year earlier and 7% below the ₹949 crore consensus—an outcome that rattled the market.
Revenue slipped 2.4% YoY to ₹7,404 crore versus the ₹7,498 crore estimate, trimming the top‑line margin and signaling tighter pricing pressure.
EBITDA declined 26.7% YoY to ₹1,388 crore, but outpaced the ₹1,371 crore consensus; the margin contracted 630 basis points to 18.7%, down from 25% in the same quarter last year.
On the business front, the One‑India segment recorded its highest‑ever quarterly sales, up 12% YoY, while North America generated $172 million—a figure that aligns with estimates and underlines the pipeline’s potential.
R&D spend stood at ₹423 crore (5.7% of sales), focused on product filings and key development programs, and the company reported a net cash position of ₹9,823 crore, with lease liabilities and working‑capital needs forming the bulk of debt.
Looking ahead, Managing Director and Global CEO Achin Gupta said Cipla will continue to leverage its strong pipeline in North America and its outperforming South African private‑market business, but no explicit guidance was issued for the next quarter.